1-10 of 10
Authors: Pooja Prasad
Sort by
Journal Article
618. A COMPARISON OF HEALTH-RELATED QUALITY OF LIFE AT ONE YEAR FOLLOWING MINIMALLY INVASIVE VERSUS OPEN ESOPHAGECTOMY Free
Pooja Prasad and others
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.327, https://doi.org/10.1093/dote/doae057.327
Published: 02 September 2024
Journal Article
616. POST-ESOPHAGECTOMY REHABILITATION IS ASSOCIATED WITH EARLY IMPROVEMENTS IN PHYSICAL FITNESS AND SARCOPENIA: PRELIMINARY RESULTS FROM THE FITNESS AFTER OESOPHAGECTOMY (FARO) TRIAL Free
Pooja Prasad and others
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.326, https://doi.org/10.1093/dote/doae057.326
Published: 02 September 2024
Journal Article
619. ASSOCIATION OF PROLONGED ONE LUNG VENTILATION TIME WITH PERIOPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING ESOPHAGOGASTRIC CANCER RESECTION Free
Pooja Prasad and others
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.328, https://doi.org/10.1093/dote/doae057.328
Published: 02 September 2024
Journal Article
465. COMPLETE RESPONSE IN BARRETT’S HIGH-GRADE DYSPLASIA WITH THE UTILISATION OF RADIOFREQUENCY ABLATION: A SYSTEMATIC REVIEW Free
Pooja Prasad and others
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.249, https://doi.org/10.1093/dote/doad052.249
Published: 30 August 2023
Journal Article
469. LONG-TERM QUALITY OF LIFE FOLLOWING ESOPHAGECTOMY FOR CANCER: RESULTS FROM A PILOT STUDY UTILIZING NOVEL TECHNOLOGY FOR PATIENT-REPORTED OUTCOMES Free
Pooja Prasad and others
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.251, https://doi.org/10.1093/dote/doad052.251
Published: 30 August 2023
Journal Article
562. PROGNOSTIC IMPACT OF CLINICOPATHOLOGICAL FEATURES FOLLOWING METASTECTOMY FOR METACHRONOUS PULMONARY METASTASIS FROM ESOPHAGEAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS Free
Pooja Prasad and others
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.562, https://doi.org/10.1093/dote/doac051.562
Published: 24 September 2022
Journal Article
523. RISK FACTORS ASSOCIATED WITH NOT RECEIVING ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED ESOPHAGOGASTRIC ADENOCARCINOMA Free
Jakub Chmelo and others
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.523, https://doi.org/10.1093/dote/doac051.523
Published: 24 September 2022
Journal Article
378. FLOT VS ECX: A COMPARISON OF TWO NEOADJUVANT CHEMOTHERAPY REGIMEN’S EFFECTS ON SARCOPENIA IN ESOPHAGOGASTRIC ADENOCARCINOMA PATIENTS Free
James Convill and others
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.378, https://doi.org/10.1093/dote/doac051.378
Published: 24 September 2022
Journal Article
566. PROGNOSTIC SIGNIFICANCE OF TUMOUR BURDEN AND OPERATIVE TECHNIQUE FOR METACHRONOUS PULMONARY METASTASIS FROM ESOPHAGEAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS Free
Pooja Prasad and others
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.566, https://doi.org/10.1093/dote/doac051.566
Published: 24 September 2022
Journal Article
460. SARCOPENIA AFTER NEOADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH DEVELOPMENT OF MODERATE TO SEVERE POST-OPERATIVE COMPLICATIONS IN ESOPHAGOGASTRIC ADENOCARCINOMA PATIENTS Free
James Convill and others
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.460, https://doi.org/10.1093/dote/doac051.460
Published: 24 September 2022
Advertisement
Advertisement